SYNHELIX
SynHelix seeks to break the bottleneck of biotherapeutics development which faces unsolved DNA constructs supply.
SYNHELIX
Industry:
Biotechnology
Founded:
2019-01-01
Address:
รvry, Ile-de-France, France
Country:
France
Website Url:
http://www.synhelix.com
Total Employee:
1+
Status:
Active
Technology used in webpage:
Google Maps OVH
Official Site Inspections
http://www.synhelix.com Semrush global rank: 11.46 M Semrush visits lastest month: 162
- Host name: a2b7bf3398455f345.awsglobalaccelerator.com
- IP address: 99.83.161.153
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108

More informations about "SynHelix"
HOME - Synhelix
Careers at SynHelix We are seeking for amazing scientists and executives to build with us the most exciting synthetic biology core platform. If you are as โฆSee details»
SynHelix - Crunchbase Company Profile & Funding
Organization. SynHelix . Connect to CRM . Save . Summary. People. Technology. Signals & News. About. ... SynHelix seeks to break the bottleneck of biotherapeutics development which โฆSee details»
SynHelix Company Profile 2024: Valuation, Investors ... - PitchBook
SynHelix General Information Description. Operator of a biotechnology company intended to develop an affordable DNA synthesis technology. The company is engaged in generating any โฆSee details»
Univercells acquires SynHelix - 2022-01-06 - Crunchbase
SynHelix SynHelix seeks to break the bottleneck of biotherapeutics development which faces unsolved DNA constructs supply. Acquiring Organization: Univercells Univercells is a One โฆSee details»
Univercells acquires SynHelix, entering into synthetic biology and โฆ
Jan 6, 2022 Univercells S.A. Univercells S.A. SynHelix Alexandra Deschner Cécile Hisette Irina Gbalou IR & International Media Relations Belgian Media Relations CEO โฆSee details»
Univercells acquires Synhelix, entering into synthetic ... - Quantoom
Jan 13, 2022 Irina Gbalou, CEO and co-founder of SynHelix added: โWe are really thrilled to join the Univercells Group. SynHelix was founded with the mission of making an impact in โฆSee details»
SynHelix - Products, Competitors, Financials, Employees, โฆ
SynHelix offers a proprietary, enzyme-based DNA synthesis solution that promises a gigaprep-scale DNA production for life sciences laboratories and industries that need large amounts of โฆSee details»
Univercells acquires SynHelix, entering into synthetic biology and โฆ
Jan 6, 2022 The SynHelix team is looking forward to working alongside Quantoomโs strong scientific, development and management teams to advance the next-generation vaccines โฆSee details»
About Us - Synhelix
SynHelix seeks to break the bottleneck of biotherapeutics development which faces unsolved DNA constructs supply, given the exponentially increasing demands from the pharma and โฆSee details»
SynHelix - Company Profile - Tracxn
Oct 20, 2024 SynHelix ranks 32nd among 47 active competitors. 16 of its competitors are funded while 9 have exited. Overall, SynHelix and its competitors have raised over $1.14B in โฆSee details»
Univercells acquires SynHelix, entering into synthetic biology and โฆ
Feb 14, 2022 SynHelix was founded with the mission of making an impact in synthetic biology, which faces a bottleneck in DNA supply. Alain Huriez and the entire AdBio partners team โฆSee details»
Univercells acquires SynHelix to advance DNA synthesis
Jan 7, 2022 The founders of SynHelix and AdBio will subsequently become minority shareholders of Univercells, according to the companies. Headquartered in Évry โฆSee details»
Univercells acquires SynHelix, enters synthetic biology field
Jan 6, 2022 โThe SynHelix team is looking forward to working alongside Quantoomโs strong scientific, development and management teams to advance the next-generation vaccines โฆSee details»
Acquisition brings combined approach to Synthetic DNA pursuit
SynHelix was founded with the mission of making an impact in synthetic biology, which faces a bottleneck in DNA supply. Alain Huriez and the entire AdBio partners team believed in us from โฆSee details»
Investors - Synhelix
SynHelix seeks to break the bottleneck of biotherapeutics development which faces unsolved DNA constructs supply, given the exponentially increasing demands from the pharma and โฆSee details»
SynHelix | EU-Startups
SynHelix seeks to break the bottleneck of biotherapeutics development which faces unsolved DNA constructs supply, given the exponentially increasing demands from the pharma and โฆSee details»
Partners - Synhelix
Since May 2019, SynHelix is accompanied by the healthcare accelerator program of WILCO after being selected by a jury of experts (composed by entrepreneurs, business angels and โฆSee details»
Irina Gbalou - Synhelix
Before founding SynHelix, Irina managed a project that aimed at engineering a human DNA polymerase to switch its activity and synthesize RNA fragments, useful to generate aptamers โฆSee details»
Ahmed Said - Synhelix
Synhelix โ Ahmed Said. Ahmed Said. Chief Technological Officer and co-founder. LinkedIn; Ahmed is a passionate biotechnology engineer. He is particularly resourceful in optimizing โฆSee details»
Technology - Synhelix
SynHelix team is devoted to the development of the most robust and scalable DNA synthesis technology using a specifically engineered high-perfomance enzyme with the advantages of: - โฆSee details»